Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: An analysis of 1,051 recent sputum isolates

Chest

Volumn 117, Issue 6, 2000, Pages 1661-1665

  McMenamin, Jennifer D ^a   Zaccone, Theresa M ^a   Coenye, Tom ^b   Vandamme, Peter ^b   LiPuma, John J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Acquisition; Burkholderia cepacia; Colonization; Cystic fibrosis; Identification

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; ERROR; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPUTUM CULTURE; UNITED STATES;

BURKHOLDERIA CEPACIA;

EID: 0034083524     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.6.1661     Document Type: Article

References (22)

1. 1 Tablan OC, Carson LA, Cusick LB, et al. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol 1987; 25:485-487
2. 2 Carson LA, Tablan OC, Cusick LB, et al. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. J Clin Microbiol 1988; 26:2096-2100
3. 3 Cystic Fibrosis Foundation. Clinical practice guidelines for cystic fibrosis. Bethesda, MD: Cystic Fibrosis Foundation, 1997
4. 4 Shreve MR, Butler S, Kaplowitz HJ, et al. Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis. J Clin Microbiol 1999; 37:753-757
5. 5 Vandamme P, Holmes B, Vancanneyt M, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients: proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol 1997; 47:1188-1200
6. 6 Coenye T, Falsen E, Hoste B, et al. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol 2000; 50:887-889
7. 7 Henry DA, Campbell ME, LiPuma JJ, et al. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol 1997; 35:614-619
8. 8 Gilligan PH. Pseudomonas and Burkholderia. In: Murray PR, ed. Manual of clinical microbiology. 6th. Washington, DC: ASM Press, 1995; 509-519
9. 9 Henry DA, Mahenthiralingam E, Vandamme P, et al. Biochemical and molecular approaches for determining genomovar status of the Burkholderia cepacia complex [abstract 377]. Pediatr Pulmonol 1999; Suppl19:271
10. 10 LiPuma JJ, Dulaney BJ, McMenamin JD, et al. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol 1999; 37:3167-3170
11. 11 Campbell PW, Phillips JA, Heidecker GJ, et al. Detection of Pseudomonas (Burkholderia) cepacia using PCR. Pediatr Pulmonol 1995; 20:44-49
12. 12 Coenye T, Schouls LM, Govan JRW, et al. Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting. Int J Syst Bacteriol 1999; 49:1657-1666
13. 13 Pitcher DG, Saunders NA, Owen RJ. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol 1989; 8:109-114
14. 14 Vandamme P, Pot B, Gillis M, et al. Polyphasic taxonomy: a consensus approach to bacterial systematics. Microbiol Rev 1996; 60:407-438
15. 15 Burdge DR, Noble MA, Campbell ME, et al. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin Infect Dis 1995; 20:445-448
16. 16 LiPuma JJ, Henry D, Mehar F, et al. Misidentification of Burkholderia cepacia [abstract 1810]. Pediatr Res 1997; 41:304A
17. 17 Henry D, Campbell M, McGimpsey G, et al. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 1999; 37:1004-1007
18. 18 Kiska DL, Kerr A, Jones MC, et al. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol 1996; 34:886-891
19. 19 van Pelt C, Verduin CM, Goessens WHF, et al. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol 1999; 37:2158-2164
20. 20 Wilsher ML, Kolbe J, Morris AJ, et al. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med 1997; 155:1436-1440
21. 21 Clode FE, Metherell LA, Pitt TL. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med 1999; 160:374-375
22. 22 Coenye T, LiPuma J, Henry D, et al. Description of a new member of the Burkholderia cepacia complex occurring in CF patients [abstract 384]. Pediatr Pulmonol 1999; Suppl19: 273